Teleflex Clears Key Antitrust Hurdle for OEM Divestiture
TipRanks (Tue, 17-Mar 5:18 PM ET)
TipRanks (Mon, 16-Mar 8:30 AM ET)
o9 Announces Teleflex Global Go-Live for Integrated Demand and Supply Planning
Business Wire (Thu, 12-Mar 8:02 AM ET)
Teleflex Sets Next Quarterly Dividend: What Investors Need to Know About This Key Announcement
Market Chameleon (Thu, 26-Feb 3:40 AM ET)
Teleflex Announces Quarterly Dividend
Business Wire (Thu, 26-Feb 6:45 AM ET)
Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook
Business Wire (Thu, 26-Feb 6:30 AM ET)
Diality Appoints Peter Donato as Chief Financial Officer
Business Wire (Tue, 24-Feb 7:05 AM ET)
Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
Business Wire (Tue, 17-Feb 6:30 AM ET)
PRNewswire (Thu, 12-Feb 6:56 PM ET)
Globe Newswire (Tue, 20-Jan 1:09 PM ET)
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Teleflex trades on the NYSE stock market under the symbol TFX.
As of March 17, 2026, TFX stock price climbed to $109.62 with 258,124 million shares trading.
TFX has a beta of 0.72, meaning it tends to be less sensitive to market movements. TFX has a correlation of 0.11 to the broad based SPY ETF.
TFX has a market cap of $4.84 billion. This is considered a Mid Cap stock.
Last quarter Teleflex reported $569 million in Revenue and $1.93 earnings per share. This fell short of revenue expectation by $-349 million and missed earnings estimates by -$1.81.
In the last 3 years, TFX traded as high as $276.43 and as low as $100.18.
The top ETF exchange traded funds that TFX belongs to (by Net Assets): IJR, VTI, VB, VBR, VXF.
TFX has underperformed the market in the last year with a price return of -19.4% while the SPY ETF gained +20.5%. TFX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.9% and -10.6%, respectively, while the SPY returned -0.9% and -2.2%, respectively.
TFX support price is $106.44 and resistance is $112.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX shares will trade within this expected range on the day.